Lecap Asset Management Ltd. Invests $761,000 in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Lecap Asset Management Ltd. acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 50,904 shares of the medical instruments supplier's stock, valued at approximately $761,000.

A number of other hedge funds have also recently added to or reduced their stakes in XRAY. Blue Trust Inc. lifted its position in shares of DENTSPLY SIRONA by 57.7% in the 1st quarter. Blue Trust Inc. now owns 12,554 shares of the medical instruments supplier's stock worth $188,000 after buying an additional 4,595 shares during the last quarter. Janney Montgomery Scott LLC lifted its holdings in DENTSPLY SIRONA by 210.5% in the first quarter. Janney Montgomery Scott LLC now owns 64,191 shares of the medical instruments supplier's stock worth $959,000 after acquiring an additional 43,516 shares during the last quarter. Hanson & Doremus Investment Management acquired a new position in DENTSPLY SIRONA in the first quarter valued at approximately $90,000. Sound Income Strategies LLC grew its holdings in shares of DENTSPLY SIRONA by 43.7% during the first quarter. Sound Income Strategies LLC now owns 347,841 shares of the medical instruments supplier's stock valued at $5,197,000 after purchasing an additional 105,777 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in shares of DENTSPLY SIRONA by 39.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier's stock valued at $805,000 after purchasing an additional 15,117 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on XRAY shares. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research note on Tuesday, April 15th. Barrington Research upped their price target on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a research report on Monday, May 12th. Mizuho cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Finally, Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $20.36.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock remained flat at $16.00 during midday trading on Thursday. 2,151,856 shares of the company's stock were exchanged, compared to its average volume of 2,938,716. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.95. The stock has a market capitalization of $3.19 billion, a P/E ratio of -3.52, a P/E/G ratio of 1.12 and a beta of 0.95. The business has a 50 day simple moving average of $15.26 and a 200 day simple moving average of $16.64. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business's revenue for the quarter was down 7.8% on a year-over-year basis. During the same quarter last year, the business earned $0.42 earnings per share. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 4.00%. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.